Literature DB >> 3463272

Barrett's esophagus: clinical, endoscopic, and histologic spectrum in fifty patients.

P Kerlin, G d'Mellow, A van Deth.   

Abstract

The columnar lined (Barrett's) esophagus is an acquired condition resulting from chronic gastroesophageal reflux. The clinical spectrum of 50 consecutive cases of endoscopically consistent, histologically proven Barrett's esophagus was reviewed. The mean age of patients was 65.9 +/- 12.4 (SD) years with only four patients younger than 50 years. The predominant presenting symptoms were dysphagia, heartburn, and regurgitation. At endoscopy, the columnar lined segment extended over 6.5 +/- 3.0 cm of the lower esophagus. Specialised columnar (intestinal) epithelium was the most frequent histological type identified. Radiologic or endoscopic evidence of a hiatal hernia was present in the majority. Complications were present at endoscopy in 38 (76%) patients. Reflux esophagitis (56%) was present at the area of the squamo-columnar junction. Stricture formation (38%) and ulceration (36%) were located either at the squamo-columnar junction or more distally within the columnar epithelium. Two patients (4%) had adenocarcinoma arising in a segment of Barrett's esophagus at presentation. Treatment included physical measures, dilatation, and cimetidine. Bougienage in 20 patients was successful in alleviating dysphagia but multiple treatment sessions were often necessary. Although esophagitis readily resolved with cimetidine therapy, ulceration was generally resistant to medical therapy. Indeed, by two months, healing was achieved in only five of 12 patients. Endoscopic surveillance of 12 patients who received cimetidine (1 g/day) for at least 12 months showed no regression of the metaplastic mucosa.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3463272     DOI: 10.1111/j.1445-5994.1986.tb01148.x

Source DB:  PubMed          Journal:  Aust N Z J Med        ISSN: 0004-8291


  9 in total

Review 1.  Barrett's oesophagus--to screen or not to screen?

Authors:  M Atkinson
Journal:  Gut       Date:  1989-01       Impact factor: 23.059

2.  Only patients with dysplasia progress to adenocarcinoma in Barrett's oesophagus.

Authors:  M Miros; P Kerlin; N Walker
Journal:  Gut       Date:  1991-12       Impact factor: 23.059

Review 3.  Photodynamic therapy: a review.

Authors:  J S McCaughan
Journal:  Drugs Aging       Date:  1999-07       Impact factor: 3.923

4.  Barrett's oesophagus.

Authors:  R C Heading
Journal:  Br Med J (Clin Res Ed)       Date:  1987-02-21

5.  Benign oesophageal stricture in Barrett's columnar epithelialised oesophagus and its responsiveness to conservative management.

Authors:  M Atkinson; C S Robertson
Journal:  Gut       Date:  1988-12       Impact factor: 23.059

6.  Regression of Barrett's esophagus by laser ablation in an anacid environment.

Authors:  R E Sampliner; L J Hixson; M B Fennerty; H S Garewal
Journal:  Dig Dis Sci       Date:  1993-02       Impact factor: 3.199

Review 7.  The neoplastic potential of columnar-lined (Barrett's) esophagus.

Authors:  G N Tytgat; W Hameeteman
Journal:  World J Surg       Date:  1992 Mar-Apr       Impact factor: 3.352

Review 8.  Epidemiology of gastro-esophageal reflux disease.

Authors:  P J Howard; R C Heading
Journal:  World J Surg       Date:  1992 Mar-Apr       Impact factor: 3.352

9.  Lack of impact of therapy on extent of Barrett's esophagus in 67 patients.

Authors:  R E Sampliner; H S Garewal; M B Fennerty; M Aickin
Journal:  Dig Dis Sci       Date:  1990-01       Impact factor: 3.199

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.